Business Context and Reporting Period
This Form 8-K, filed on January 23, 2024, reports that Purple Innovation, Inc. (PRPL) entered into a material definitive agreement to restructure its debt financing. The filing details the execution of a Second Amendment to its Term Loan Agreement and an Amended and Restated Credit Agreement with a new group of lenders, including Coliseum Capital Partners, L.P., Blackwell Partners LLC, and Harvest Small Cap Partners.
Key Financial Metrics
- Debt Financing: The company secured a new term loan of $61.0 million to Purple Innovation, LLC.
- Net Proceeds: After expenses, the transaction provided approximately $27 million in net proceeds to the Company.
- Liquidity Impact: Net liquidity (cash, cash equivalents, and ABL availability) increased from approximately $26 million immediately preceding the transaction to approximately $48 million subsequent to the transaction.
- Interest Rate: The loan bears interest at the Secured Overnight Financing Rate (SOFR) with a 3.5% floor, plus 8.25% per annum (or 10.25% if paid in kind).
- Maturity Date: December 31, 2026.
- Equity Issuance: The company issued warrants to purchase 20,000,000 shares of Class A Common Stock at an exercise price of $1.50 per share.
Material Changes Versus Prior Period
- Refinancing: The new agreement refinances existing obligations under the previous Term Loan Agreement. The previous Asset-Based Lending (ABL) facility was paid in full and terminated.
- Lender Change: Rights and obligations were assumed by a new group of lenders (CCP, Blackwell, Harvest, HSCP) and Delaware Trust Company as the administrative agent.
- Covenant Structure: The new agreement removes restrictions and requirements customarily associated with an asset-based loan, replacing them with standard affirmative and negative covenants.
- Prepayment Penalties: New penalties apply: 1.25% for prepayments between August 7, 2024, and August 7, 2025, and 2.50% thereafter.
Guidance, Outlook, and Risks
- Guidance: The company reaffirmed its previously provided guidance for net revenue and adjusted EBITDA for 2023.
- Dividend Restrictions: While amounts are outstanding, the Loan Parties are restricted from paying dividends or making other distributions on capital stock, subject to limited exceptions.
- Warrant Terms: Warrants expire 10 years from issuance. They include anti-dilution protections and a redemption right for the company if the stock price exceeds $24.00 per share for 20 trading days within a 30-day period.
- Risks: The filing includes standard forward-looking statement disclaimers, noting that actual results may differ due to risks outlined in the company's 10-K and 10-Q filings. The company noted it cannot provide a quantitative reconciliation of non-GAAP measures to GAAP without unreasonable effort due to unpredictable adjusting items.
Investor Verification Checklist
- Verify the exact terms of the $61.0 million term loan and the $19.0 million incremental loan option in the full Amended and Restated Credit Agreement (Exhibit 10.1).
- Review the warrant exercise price of $1.50 and the specific anti-dilution adjustment mechanisms, including the $0.8502 floor price.
- Confirm the impact of the termination of the ABL facility on future working capital flexibility.
- Assess the prepayment penalties and their impact on future debt management strategies.
- Examine the Registration Rights Agreement (Exhibit 10.3) regarding the potential dilution from the resale of the 20 million warrant shares.